Published in Blood Weekly, April 23rd, 2009
" Twenty-five patients with unstable angina and non-ST-segment elevation myocardial infarction received eptifibatide on admission (two 180 mu g/kg boluses followed by infusion at 2.0 and 1.3 mu g/kg/min for 24 and 48 h, respectively) and 25 were treated without GP IIb-IIIa antagonists....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.